← Back
Data updated: Mar 10, 2026
ZENARA
Neurology
ZENARA is a generic drug manufacturer focused on Neurology. Key products include SERTRALINE HYDROCHLORIDE.
2025
Since
5
Drugs
-
Trials
53
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
PRUCALOPRIDE SUCCINATE 2026-02-05
PRUCALOPRIDE SUCCINATE 2026-01-29
Labeling
SERTRALINE HYDROCHLORIDE 2026-01-29
SERTRALINE HYDROCHLORIDE 2026-01-28
SERTRALINE HYDROCHLORIDE 2026-01-20
SERTRALINE HYDROCHLORIDE 2026-01-20
SERTRALINE HYDROCHLORIDE 2026-01-20
PRUCALOPRIDE SUCCINATE 2026-01-16
SAPROPTERIN DIHYDROCHLORIDE 2026-01-08
SERTRALINE HYDROCHLORIDE 2025-11-20
Manufacturing (CMC)
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (2)
Company Info
- First Approval
- 2025-06-11
- Latest
- 2025-07-16
- Applications
- 5